Matinas Biopharma Holdings, Inc. (NYSE:MTNB – Get Free Report) traded down 0% on Friday . The company traded as low as $0.56 and last traded at $0.58. 75,969 shares changed hands during mid-day trading, a decline of 89% from the average session volume of 672,492 shares. The stock had previously closed at $0.58.
Matinas Biopharma Stock Down 0.0 %
The stock’s fifty day moving average price is $0.60. The company has a market cap of $2.95 million, a P/E ratio of -0.12 and a beta of 1.59.
Matinas Biopharma Company Profile
Matinas BioPharma Holdings, Inc is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D.
Read More
- Five stocks we like better than Matinas Biopharma
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Realty Income: An Anchor in Volatile Markets
- What is a SEC Filing?
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Investing in Construction Stocks
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
Receive News & Ratings for Matinas Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Matinas Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
